| Primary |
| Product Used For Unknown Indication |
15.5% |
| Drug Use For Unknown Indication |
12.7% |
| Sinusitis |
12.7% |
| Asthma |
8.5% |
| Anxiety |
5.6% |
| Pyrexia |
5.6% |
| Depression |
4.2% |
| Diverticulum |
4.2% |
| Ear Infection |
4.2% |
| Hypersensitivity |
4.2% |
| Rhinitis Allergic |
4.2% |
| Chronic Sinusitis |
2.8% |
| Nausea |
2.8% |
| Rhinitis Perennial |
2.8% |
| Vomiting |
2.8% |
| Alveolitis |
1.4% |
| Antiinflammatory Therapy |
1.4% |
| Bacterial Infection |
1.4% |
| Contusion |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
|
| Pyrexia |
13.8% |
| Cataract |
10.3% |
| Osteonecrosis |
6.9% |
| Transient Ischaemic Attack |
6.9% |
| Weight Decreased |
6.9% |
| Weight Increased |
6.9% |
| Acute Generalised Exanthematous Pustulosis |
3.4% |
| Anosmia |
3.4% |
| Chorioretinopathy |
3.4% |
| Delusion |
3.4% |
| Diarrhoea Haemorrhagic |
3.4% |
| Drug Interaction |
3.4% |
| Glaucoma |
3.4% |
| Hepatocellular Injury |
3.4% |
| Insomnia |
3.4% |
| Lupus-like Syndrome |
3.4% |
| Migraine |
3.4% |
| Nasal Necrosis |
3.4% |
| Osteopenia |
3.4% |
| Overdose |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
18.0% |
| Asthma |
14.4% |
| Upper Respiratory Tract Infection |
12.6% |
| Drug Use For Unknown Indication |
9.9% |
| Sinusitis |
9.0% |
| Hypersensitivity |
5.4% |
| Rhinitis Allergic |
4.5% |
| Anxiety |
3.6% |
| Bronchitis |
3.6% |
| Seasonal Allergy |
3.6% |
| Multiple Allergies |
2.7% |
| Chest Discomfort |
1.8% |
| Eustachian Tube Dysfunction |
1.8% |
| Infection |
1.8% |
| Post Procedural Infection |
1.8% |
| Rhinitis |
1.8% |
| Antiinflammatory Therapy |
0.9% |
| Bacterial Infection |
0.9% |
| Benign Prostatic Hyperplasia |
0.9% |
| Chronic Myeloid Leukaemia |
0.9% |
|
| Throat Irritation |
16.7% |
| Insomnia |
13.3% |
| Hepatitis Toxic |
6.7% |
| Psychiatric Decompensation |
6.7% |
| Tendon Rupture |
6.7% |
| Death |
3.3% |
| Diarrhoea |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Epistaxis |
3.3% |
| Eye Irritation |
3.3% |
| Headache |
3.3% |
| Hyperadrenocorticism |
3.3% |
| Ill-defined Disorder |
3.3% |
| Increased Upper Airway Secretion |
3.3% |
| Lupus-like Syndrome |
3.3% |
| Mental Disorder |
3.3% |
| Migraine |
3.3% |
| Neutrophil Percentage Decreased |
3.3% |
| Off Label Use |
3.3% |
| Oropharyngeal Pain |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Drug Use For Unknown Indication |
17.1% |
| Asthma |
13.4% |
| Hypertension |
6.2% |
| Hypersensitivity |
5.9% |
| Pain |
3.6% |
| Osteoporosis |
3.4% |
| Depression |
2.6% |
| Multiple Allergies |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Blood Cholesterol Increased |
2.1% |
| Anxiety |
2.1% |
| Diabetes Mellitus |
2.0% |
| Contraception |
1.9% |
| Seasonal Allergy |
1.8% |
| Hormone Replacement Therapy |
1.6% |
| Rhinitis Allergic |
1.6% |
| Multiple Myeloma |
1.5% |
|
| Vomiting |
14.7% |
| Weight Decreased |
9.6% |
| Weight Increased |
7.2% |
| Nausea |
6.0% |
| Tremor |
5.5% |
| Dyspnoea |
4.9% |
| Vision Blurred |
4.9% |
| Wheezing |
4.9% |
| Throat Irritation |
4.7% |
| Pharmaceutical Product Complaint |
4.5% |
| Pain |
4.1% |
| Rash |
4.1% |
| Pulmonary Embolism |
3.8% |
| Myocardial Infarction |
3.6% |
| Pain In Extremity |
3.2% |
| Urticaria |
3.2% |
| Tinnitus |
3.0% |
| Drug Ineffective |
2.8% |
| Urinary Tract Infection |
2.8% |
| Death |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
65.4% |
| Chronic Obstructive Pulmonary Disease |
15.4% |
| Hiv Infection |
15.4% |
| Diabetes Mellitus |
3.8% |
|
| Pulse Absent |
33.3% |
| Renal Failure |
33.3% |
| Urinary Tract Infection |
33.3% |
|
